Planning for long-term use, including the cost implications , is a practical necessity
Semaglutide generic launches in other countries Semaglutide is still under patent in the U.S., but other countries may allow generics sooner due to different patent laws and expiration dates
July 2024: A study that examined the link between taking semaglutide drugs and suffering eye strokes is in the news
Diarrhea affects 16-34% of retatrutide users depending on dose, making it the second most common GI side effect after nausea
Wegovy injections are FDA-approved for weight management in children 12 and up and adults with obesity (a body mass index BMIof 30 kg/m2 or greater) or overweight adults (a BMI of 27 kg/m2 or greater) who also have weight-related health conditions such as hypertension (high blood pressure), high cholesterol, or obstructive sleep apnea
GLP-1 receptor activation contributes glucose-dependent insulin secretion and central appetite suppression